Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Innate Aminoglycoside Resistance of Achromobacter xylosoxidans Is Due to AxyXY-OprZ, an RND-Type Multidrug Efflux Pump

24 Oct 2012

Abstract excerpt

Achromobacter xylosoxidans is an innately multidrug-resistant pathogen which is emerging in cystic fibrosis (CF) patients. We characterized a new resistance-nodulation-cell division (RND)-type multidrug efflux pump, AxyXY-OprZ. This system is responsible for the intrinsic high-level resistance of A. xylosoxidans to aminoglycosides (tobramycin, amikacin, and gentamicin). Furthermore, it can extrude cefepime,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Cystic Fibrosis Research Advances
Share to Infections and bacterial resistance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23089757
DOI: 10.1128/aac.01243-12

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Innate Aminoglycoside Resistance of Achromobacter xylosoxidans Is Due to AxyXY-OprZ, an RND-Type Multidrug Efflux PumpPMID 23089757Read ↗

<i>Achromobacter xylosoxidans</i> isolates exhibit genome diversity, variable virulence, high levels of antibiotic resistance and potential intrahost evolutionSemantic proximity Read ↗

Achromobacter xylosoxidans isolates exhibit genome diversity, variable virulence, high levels of antibiotic resistance, and potential intrahost evolution.Semantic proximity Read ↗

Update on Multidrug Resistance Efflux Pumps in Acinetobacter spp.Semantic proximity Read ↗

MexXY multidrug efflux system of Pseudomonas aeruginosaSemantic proximity Read ↗

JMM Profile: Achromobacter xylosoxidans: the cloak-and-dagger opportunistSemantic proximity Read ↗

Structural and functional diversity of Resistance-Nodulation-Division (RND) efflux pump transporters with implications for antimicrobial resistanceSemantic proximity Read ↗

Pathogenesis of Achromobacter xylosoxidans respiratory infections: colonization, persistence, and transcriptome profiling in synthetic cystic fibrosis sputum mediumSemantic proximity Read ↗

Resistance in gram-negative bacilli: the emergence of RND efflux pumpsSemantic proximity Read ↗

Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes.Semantic proximity Read ↗

<i>Achromobacter xylosoxidans</i> respiratory tract infections in cystic fibrosis patientsSemantic proximity Read ↗

RND pumps across the genus Acinetobacter: AdeIJK is the universal efflux pumpSemantic proximity Read ↗

Characteristics and Diversity of Mutations in Regulatory Genes of Resistance-nodulation-cell Division Efflux Pumps in Association With Drug-resistant Clinical Isolates of Acinetobacter BaumanniiSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.